These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania. Matee MI, Lyamuya EF, Mbena EC, Magessa PM, Sufi J, Marwa GJ, Mwasulama OJ, Mbwana J. East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119 [Abstract] [Full Text] [Related]
7. Detection of HTLV-I and -II in Scottish blood donor samples and archive donations. Davidson F, Lycett C, Jarvis LM, Kerr D, Lumley S, Petrik J, Dow BC. Vox Sang; 2006 Oct; 91(3):231-6. PubMed ID: 16958835 [Abstract] [Full Text] [Related]
11. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. El-Hazmi MM. Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374 [Abstract] [Full Text] [Related]
12. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus. Seed CR, Kiely P, Keller AJ. Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258 [Abstract] [Full Text] [Related]
14. [The actual risk of retrovirus transmission from transfusions]. Soriano V, Mas A. Sangre (Barc); 1995 Oct; 40(5):407-16. PubMed ID: 8553176 [No Abstract] [Full Text] [Related]
15. Implications of human T-lymphotropic virus type-I and type-II testing in donors and patients. Fischer HE, Lichtiger B, Glassman AB. Ann Clin Lab Sci; 1995 Oct; 25(5):373-80. PubMed ID: 7486811 [Abstract] [Full Text] [Related]
16. Transmission of human T-lymphotropic virus types I and II by blood transfusion. A retrospective study of recipients of blood components (1983 through 1988). The American Red Cross HTLV-I/II Collaborative Study Group. Sullivan MT, Williams AE, Fang CT, Grandinetti T, Poiesz BJ, Ehrlich GD. Arch Intern Med; 1991 Oct; 151(10):2043-8. PubMed ID: 1929693 [Abstract] [Full Text] [Related]
17. Risk factors for human immunodeficiency virus infection among blood donors in Sao Paulo, Brazil, and their relevance to current donor deferral criteria. de Almeida Neto C, McFarland W, Murphy EL, Chen S, Nogueira FA, Mendrone A, Salles NA, Chamone DA, Sabino EC. Transfusion; 2007 Apr; 47(4):608-14. PubMed ID: 17381618 [Abstract] [Full Text] [Related]
18. Current value of serologic test for syphilis as a surrogate marker for blood-borne viral infections among blood donors in the United States. Zou S, Notari EP, Fang CT, Stramer SL, Dodd RY. Transfusion; 2009 Apr; 49(4):655-61. PubMed ID: 19170999 [Abstract] [Full Text] [Related]
19. HTLV-I in HIV seropositive Indian blood donors. Malhotra VL, Lakshmy A. J Commun Dis; 1996 Dec; 28(4):270-2. PubMed ID: 9057451 [Abstract] [Full Text] [Related]
20. [The significance of HTLV-1 and HIV-2 for transfusion medicine in Europe]. Gürtler L. Beitr Infusionsther; 1989 Dec; 24():27-32. PubMed ID: 2481545 [Abstract] [Full Text] [Related] Page: [Next] [New Search]